Actualités & Evénements

Tracking the growth in Medical Tourism: OECD helps Ministers shape the debate

27-oct.-2009

International trade in health services has been attracting increasing attention from health analysts, public health policy makers, and trade and tourism promotion agencies but with relatively little data to inform them. This statement was made by David Morgan of the Health Division at a roundtable meeting of ministers of health and tourism at the Medical Tourism and Global Health Congress, Los Angeles, October 26th-28th, 2009.

Publication of the 2007 OECD List of High Production Volume Chemicals

26-oct.-2009

The OECD List of High Production Volume (HPV) Chemicals serves as the overall priority list from which chemicals are selected for SIDS data gathering and testing and initial hazard assessment. It is compiled by the OECD Secretariat on the basis of regular submissions by Member countries reporting those industrial chemicals for which a Chemical Abstracts Service (CAS) Registry Number had been assigned and which are produced or imported at levels greater than 1000 tonnes per year.

Islande : Une période délicate pour la politique monétaire et budgétaire

16-oct.-2009

La politique monétaire et budgétaire est confrontée à de graves problèmes: le système bancaire s’est effondré; l’économie traverse une profonde récession; le taux de change s’est beaucoup déprécié; les mouvements de capitaux se sont interrompus; l’inflation est forte; la dette publique a augmenté; des sources de recettes ont disparu; les besoins sociaux se sont accrus; les ressources du fonds d’assurance chômage sont presque épuisées.

Why does the United States spend so much more on health than other countries?

09-oct.-2009

The United States spent 16% of its national income (GDP) on health in 2007, which is by far, the highest share in the OECD and more than seven percentage points higher than the average of 8.9% in OECD countries. This presentation was given by Mark Pearson, Head of OECD Health Division, to the U.S Senate Special Committee on Aging.

New and updated Test Guidelines!

11-sept.-2009

Ten new Test Guidelines and six updated Test Guidelines have been adopted by Council on 7 September 2009.

Dix nouvelles Lignes directrices et six Lignes directrices mises à jour ont été adoptées!

11-sept.-2009

Dix nouvelles Lignes directrices et six Lignes directrices mises à jour ont été adoptées par le Conseil de l’OCDE le 7 septembre 2009.

OECD Working Party on Manufactured Nanomaterials: 6th meeting

du 28-oct.-2009 au 30-oct.-2009

The 6th Meeting of the WPMN was held on 28-30 October 2009. During this meeting, the WPMN discussed the targets that need to be set in order to implement the Programme of Work 2009-2012. Accordinlgy, the WPMN agreed the updated Operational Plans for 2009-2012 for each of its projects and a new project on Co-operation on the Environmental Sustainability Use of Nanotechnology. Finally, the WPMN discussed how to continue progress on the Sponsorship Programme for the Testing of Manufactured Nanomaterials .

OECD Workshop Risk Assessment of Manufactured Nanomaterials in a Regulatory Context

du 16-sept.-2009 au 18-sept.-2009

This workshop was held on 16-18 September 2009 in Washington D.C., United States. This Workshop was co-hosted with the Business and Industry Advisory Committee to OECD (BIAC) and the Society for Risk Analysis (SRA). The  objectives were: i) to collect expert input to the critical issues specific for the risk assessments of nanomaterials; ii) to identify possible approaches for risk assessment based on the current state of knowledge; and iii) to identify issues which may be addressed through OECD’s testing programme. The workshop report will be available towards the end of the year.

OECD Workshop on Sustainability of Bio-based Products

du 23-juil.-2009 au 24-juil.-2009

Some of the topics dicussed at this workshop held on Montreal, Canada were: existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels.

International Symposium on Opportunities and Challenges in the Emerging Field of Synthetic Biology

du 09-juil.-2009 au 10-juil.-2009

Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms. However, achieving the rewards offered by synthetic biology will require addressing a range of social, economic, ethical, and legal issues as well as overcoming scientific and technical challenges. Given the enormous promise of synthetic biology, it is critical to develop a framework and to engage the public in an informed dialogue.

OECD Conference on Potential Environmental Benefits of Nanotechnology: Fostering Safe Innovation-Led Growth

du 15-juil.-2009 au 17-juil.-2009

The OECD Working Party on Manufactured Nanomaterials (WPMN) and the OECD Working Party on Nanotechnology (WPN) recently held a Conference on Potential Environmental Benefits of Nanotechnolgy: Fostering Safe Innovation-Led Growth on 15-17 July in 2009 at the OECD Conference Centre in Paris, France. The conference  covered both the opportunities and the challenges of the use of nanotechnologies for the potential benefits for the environment.

OECD Published Pov and LRTP Screening Tool

OECD published the "Pov and LRTP Screening Tool" which has been developed with the aim of using multimedia models for estimating overall persistence (Pov) and long-range transport potential (LRTP) of organic chemicals at a screening level in the context of PBTs/POPs assessments. The Tool calculates metrics of Pov and LRTP from a multimedia chemical fate model, and provides a graphical presentation of the results.

Expert meeting on biomarkers and targetted therapies

du 06-oct.-2008 au 07-oct.-2008

An expert workshop will be held in Cambridge, United Kingdom, to discuss a number of analytical papers that address some key policy issues in the development and uptake of biomarkers. A policy report based on the papers and the workshop discussion is planned for delivery before the end of 2008.

Forum de l’OCDE sur les médicaments destinés à lutter contre les maladies infectieuses négligées et émergentes, Hôtel van Oranje, Noordwijk-aan-Zee, Pays-Bas, 20-21 juin 2007

du 20-juin-2007 au 21-juin-2007

 Les maladies infectieuses et négligées font souffrir les familles, la société et l’économie, en particulier dans les pays en voie de développement. Selon l’Organisation mondiale de la santé, un milliard d’êtres humains souffriraient de ces maladies, contre lesquelles il existe peu de nouveaux outils thérapeutiques ou traitements. Le Forum de haut niveau de l’OCDE sur les maladies infectieuses négligées et émergentes examinera les moyens à mettre en œuvre pour améliorer la situation.

Travaux de l'OCDE portant sur les priorités du G8 au Sommet de 2006

du 15-juil.-2006 au 17-juil.-2006

Le Sommet du G8 de cette année a eu lieu à Saint-Pétersbourg, Russie. Les principales priorités établies par le Président Vladimir Putin ont été la sécurité énergétique mondiale, l'éducation et la lutte contre les maladies infectieuses. Cliquez ici pour trouver les rapports de l'OCDE portant sur ces sujets et les autres questions abordées au Sommet de 2006.